Search for: "SMITH v. MERCK & CO., INC." Results 21 - 40 of 53
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Aug 2012, 10:09 pm by FDABlog HPM
  This long-running litigation involves a challenge by direct purchasers of K-DUR (potassium chloride) Extended-release Tablets who allege that Merck & Co., Inc. [read post]
13 Aug 2015, 10:56 am
  This principle could certainly apply to innovator manufacturers as well in circumstances where the manufacturer could not make the proposed changes without government assistance.Mutual Pharmaceutical Co., Inc. v. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
22 Jun 2011, 4:09 am by Marie Louise
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods:  Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche… [read post]
2 Mar 2012, 6:52 am by Bexis
Merck (Vioxx) Trial2006-05-08 Doherty v. [read post]
6 Jul 2007, 4:29 am
Upjohn Co., 778 A.2d 829, 836-38 (Conn. 2001); Coyle v. [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
24 May 2007, 10:40 am
Upjohn Co., 778 A.2d 829, 846 (Conn. 2001); Niemiera v. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]